WILMINGTON, MA, Jun 25, 2012 (MARKETWIRE via COMTEX) --Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a
high technology supplier of systems and sensors for homeland security
and defense markets, today announced that Mr. Robert J. Franks has
become an Advisor to the Company. Mr. Franks is a highly regarded
security expert who has held senior posts with the U.S. Department of
State, the U.S. Mission to the United Nations, and private industry.
He brings his extensive knowledge of security and law enforcement,
along with his relationships with senior-most decision makers at
numerous U.S. and international security organizations to Implant
Sciences.
Mr. Franks, a 26 year veteran of the U.S. State Department, served as
an Assistant Director of the Diplomatic Security Service. While at
the Diplomatic Security Service, he also served as Director of
International Operations where he managed overseas security and law
enforcement for all State Department missions abroad. His
responsibilities included operational control over 1,300 Marine
Security Guards and all embassy Regional Security Officers. Mr.
Franks met regularly with the highest echelons of White House, State
Department, Defense Department, and U.S. Intelligence Agencies
regarding security matters affecting U.S. foreign policy. He also
served as Director of Dignitary Protection, responsible for the
protection of the Secretary of State and all foreign dignitaries
visiting the United States. Additionally, Mr. Franks served as the
Supervisory Regional Security Officer at the U.S. Embassies in Japan
and Russia, and Special Assistant for Countermeasure and Information
Security at Diplomatic Security Service. Prior to his overseas
assignments, he served as a Special Agent with the Diplomatic
Security Service for 15 years. Mr. Franks has received numerous
awards, honors, and commendations during his years of service from
the U.S. Department of State, the U.S. Department of Justice, the
FBI, the DEA, and the U.S. Secret Service.
Mr. Franks most recently was employed as an Account Executive with
EOD Technology, where he was responsible for overseeing the U.S.
Department of State's security support account, a 5-year,
multi-billion dollar security services contract. In this role he
managed over 700 security specialists assigned to U.S. Embassies.
Prior to that, he was Principal Security Advisor to the U.S. Mission
to The United Nations where he was responsible for all matters
related to the security of foreign missions accredited to the United
Nations. During his time in private industry, Mr. Franks served as
Director of Corporate Security at Time, Inc., where he was
responsible for the company's corporate security program.
"Robert has a keen understanding of the clear benefits our Quantum
Sniffers(TM) offer in multi-layered security environments for both
government and corporate security environments. His long-standing
relationships with senior staff in federal law enforcement and
security personnel at organizations, including the U.S. Department of
State, the U.S. Secret Service, and the Department of Homeland
Security's Critical Infrastructure, will open doors for the Company,"
stated Implant Sciences' President and CEO, Glenn D. Bolduc.
About Implant Sciences
Implant Sciences develops, manufactures and sells sophisticated
sensors and systems for Security, Safety, and Defense (SS&D) markets.
The Company has developed proprietary technologies used in its
commercial explosive and narcotics trace detection systems which ship
to a growing number of locations domestically and internationally.
Implant Sciences' QS-H150 portable explosives trace detector has
received Qualified Anti-Terrorism Technology Designation and the
Company's QS-B220 bench-top explosives and narcotics trace detector
has received a Developmental Testing & Evaluation (DT&E) Designation
by the U.S. Department of Homeland Security under the Support
Anti-terrorism by Fostering Effective Technology Act of 2002 (the
SAFETY Act). For further details on the Company and its products,
please visit the Company's website at www.implantsciences.com
Safe Harbor Statement
This press release may contain certain "forward-looking statements,"
as that term is defined in the Private Securities Litigation Reform
Act of 1995. Such statements are based on management's current
expectations and are subject to risks and uncertainties that could
cause the Company's actual results to differ materially from the
forward-looking statements. Such risks and uncertainties include, but
are not limited to, the risks that our explosives detection products
and technologies (including any new products we may develop) may not
be accepted by the Transportation Security Administration or by other
U.S. or foreign government and law enforcement agencies or commercial
consumers of security products; economic, political and other risks
associated with international sales and operations could adversely
affect our sales; our business is subject to intense competition and
rapid technological change; the risks that our markets are subject to
technological change and that our success depends on our ability to
develop and introduce new products; that our success depends on our
ability to obtain new patents and operate without infringing on the
proprietary rights of others; that we may not obtain the patents we
have applied for; that the validity and breadth of claims in
technology patents involve complex legal and factual questions and,
therefore, may be highly uncertain; that any patents we may obtain
may be may be challenged and subsequently invalidated, that we may
incur substantial costs in asserting our patent rights; and other
risks and uncertainties described in our filings with the Securities
and Exchange Commission, including its most recent Forms 10-K, 10-Q
and 8-K. Such statements are based on management's current
expectations and assumptions which could differ materially from the
forward-looking statements.
Contact:
Implant Sciences Corporation
Company Contact:
Glenn Bolduc
CEO
978-752-1700
Email Contact
or
Investor Contact:
Laurel Moody
646-810-0608
Email Contact
SOURCE: Implant Sciences Corporation
http://www2.marketwire.com/mw/emailprcntct?id=CE7279195AC8AEBC
http://www2.marketwire.com/mw/emailprcntct?id=CE942FB5EDBCD77C
